Mark STOPFER, Senior Principal Investigator, PhD
![](https://i1.rgstatic.net/ii/profile.image/277259601629189-1443115248435_Q512/Mark-Stopfer.jpg)
Dr. Stopfer received his B.S. and Ph.D. from Yale University with Tom Carew. He then joined Gilles Laurent's laboratory at the California Institute of Technology where he examined the information processing properties that emerge within ensembles of neurons, focusing particularly upon oscillatory and synchronous neural activity. Dr. Stopfer came to NIH in 2002. His laboratory studies neural ensemble mechanisms underlying sensory coding in relatively simple animals.
![](https://assets.isu.pub/document-structure/210204143800-2f36ab74f0499525d97bfb860242a3fa/v1/4e5b68c09ded5f3559dc75178c43da7f.jpg)
Nursing News - Issuu
![](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs13187-015-0894-0/MediaObjects/13187_2015_894_Figb_HTML.gif)
Program and Abstracts Journal of Cancer Education
![](https://www.salk.edu/wp-content/uploads/2015/10/Sejnowski-Web.jpg)
Publications - Salk Institute for Biological Studies
![](https://www.researchgate.net/profile/Mark-Stopfer/publication/267928842/figure/fig1/AS:390764338139138@1470176886344/figure-fig1_Q320.jpg)
Mark STOPFER, Senior Principal Investigator, PhD, National Institutes of Health, MD, NIH, Division of Intramural Research (NICHD)
![](https://annualreport.nichd.nih.gov/images/stopfer_2022_fig1.png)
2022 Annual Report of the Division of Intramural Research, NICHD
![](https://www.ahajournals.org/cms/asset/0b9cd481-2775-4591-8268-773aa9ffc7ed/1232fig02.jpg)
Endothelin: 30 Years From Discovery to Therapy
![](https://img.yumpu.com/6806322/1/500x640/abstracts-association-for-chemoreception-sciences.jpg)
ABSTRACTS - Association for Chemoreception Sciences
![](https://img.yumpu.com/39395838/1/500x640/annual-meeting-program-association-for-chemoreception-sciences.jpg)
Annual Meeting Program - Association for Chemoreception Sciences
![](https://ascpt.onlinelibrary.wiley.com/cms/asset/e124ee25-c46f-4468-af86-4ff4ca72710c/cts12386-fig-0007-m.jpg)
Toward Optimum Benefit‐Risk and Reduced Access Lag For Cancer Drugs in Asia: A Global Development Framework Guided by Clinical Pharmacology Principles - Venkatakrishnan - 2016 - Clinical and Translational Science - Wiley Online Library
![](https://www.researchgate.net/publication/366715740/figure/fig5/AS:11431281110445773@1672545011792/OR-protein-family-phylogeny-including-putative-SameORs-and-two-other-members-of-the_Q320.jpg)
Mark STOPFER, Senior Principal Investigator, PhD, National Institutes of Health, MD, NIH, Division of Intramural Research (NICHD)
![](https://irp.nih.gov/sites/default/files/media/image/2022-04/mark-stopfer.jpg)
Colleagues: Recently Tenured NIH Intramural Research Program